Latest news with #ContractManufacturing
Yahoo
4 days ago
- Business
- Yahoo
Global Contract Manufacturing Market on Track for $968.7 Billion by 2030
"With rising demand across pharma, electronics, and automotive sectors, contract manufacturing offers cost savings, supply chain stability, and access to specialized expertise, making it a strategic choice for future growth." BOSTON, Aug. 12, 2025 /PRNewswire/ -- According to the latest study from BCC Research, the "Contract Manufacturing: Global Markets to 2030" is projected to grow from $686.4 billion in 2025 to $968.7 billion by the end of 2030, at a compound annual growth rate (CAGR) of 7.1% during the forecast period of 2025 to 2030. This report offers a detailed look at the contract manufacturing market, analyzing it by contract type, distribution channel, and end-use industry. It explores the technological developments, regulatory factors, and competitive dynamics, along with economic trends influencing the market. Highlights include a patent analysis a discussion of ESG trends, and an evaluation of emerging technologies. The report also provides regional insights across North America, Europe, Asia-Pacific, and the Rest of the World, and concludes with profiles of major industry players. This report is particularly relevant today due to the rising consumer demand in healthcare and electronics. Contract manufacturers help OEMs meet this demand by allowing them to focus on core strengths, reduce costs, and scale efficiently, resulting in faster market entry and improved product quality. It provides a clear view of the current market, and future opportunities, and a five-year forecast for strategic planning. Additionally, it analyzes macroeconomic factors across regions to support both established and emerging players in developing effective strategies. The factors driving the market's growth include: Increasing Demand for Outsourcing: Companies are increasingly outsourcing manufacturing to reduce costs, improve efficiency, and focus on core business areas like innovation and marketing. Contract manufacturers offer specialized expertise and scalable production, making them attractive partners across industries. Growing Expansion of the Consumer Electronics Industry: The rapid growth of consumer electronics, including smartphones, wearables, and smart devices, is driving demand for high-volume, precision manufacturing. Contract manufacturers help meet this demand with advanced capabilities and global supply chain support. Technological Advances in the Manufacturing Sector: Innovations such as automation, AI, and smart factories are transforming manufacturing. Contract manufacturers adopting these technologies can offer faster, more flexible, and cost-effective production for clients. Increasing Investment in Healthcare Infrastructure: Global investments in healthcare, especially in emerging markets, are boosting demand for medical devices, pharmaceuticals, and diagnostics. Contract manufacturers play a key role in supplying these products efficiently and in compliance with regulations. Increasing Collaboration Between Contract Manufacturers and Pharmaceutical Companies: Pharmaceutical giants are partnering with contract manufacturers to streamline drug development, production, and distribution. These collaborations help reduce time-to-market, manage costs, and navigate complex regulatory environments, especially for biologics and specialty drugs. Request a sample copy of the global market for contract manufacturing report. Report Synopsis Report Metric Details Base year considered 2024 Forecast period considered 2025-2030 Base year market size $648.5 billion Market size forecast $968.7 billion Growth rate CAGR of 7.1% for the forecast period of 2025-2030 Segments covered Contract Type, Distribution Channel, End-Use Industries and Region Regions covered North America, Europe, Asia-Pacific, and Rest of the World Countries covered U.S., Canada, U.K., Germany, France, Italy, Spain, China, India, Japan, Middle East and Africa, and South America Market drivers Increasing demand for outsourcing. Growing expansion of the consumer electronics industry. Technological advances in the manufacturing sector. Increasing investment in healthcare infrastructure. Increasing collaboration between contract manufacturers and big pharmaceutical companies. Interesting facts: Advanced technologies like automation and robotics have revolutionized contract manufacturing, enabling real-time data collection, analysis, and utilization. This transformation has significantly improved the efficiency and responsiveness of manufacturing processes. In 2024, the direct tender segment accounted for the largest market share at 74.1%, driven by a surge in contracts through direct tender distribution channels. Large-scale industries increasingly favor direct tenders due to the benefits they offer to OEMs. The Asia-Pacific region led the global contract manufacturing market in 2024 with a 38.4% share, and is expected to reach a market value of $354.4 billion by 2030. This growth is fueled by rising investments in consumer electronics and the rapid expansion of the healthcare and pharmaceutical sectors. Emerging startups: Mefron: Mefron is an Indian startup that provides electronic manufacturing services across various applications and industries and delivers value-added engineering services. IndyGeneUS Bio: IndyGeneUS Bio is an innovative cell and gene therapy company focused on diversity-driven gene target discoveries and data security. In 2024, the company raised $1.8 million in a round of funding, which will help it create a blockchain-encrypted repository dedicated to clinical and multi-omics data. AtomVie: AtomVie is a CDMO with in-depth experience in GMP radiopharmaceutical manufacturing, including expertise in radiolabeling with an array of radioisotopes. The company has delivered more than 3,000 doses since 2023 with 99% accuracy across 26 countries and six continents within 72 hours. The report addresses the following questions: What are the projected market size and growth rate? - The market is projected to reach $969 billion by the end of 2030, at a CAGR of 7.1% during the forecast period. Which factors are driving the growth of the market?- The key factors driving the growth of the market are:- Increasing demand for outsourcing products.- Expansion of the consumer electronics industry.- Technological advances in the manufacturing sector. Which market segments are covered in the report?- Contract type- Distribution channel- End-Use industry. Which end-use industry will be dominant through 2030?- The consumer electronics segment will dominate the market through 2030. Which region has the largest market share?- The Asia-Pacific region holds the largest share of the global contract manufacturing market. Market leaders Include: AENOVA HOLDING GMBH BENCHMARK ELECTRONICS INC. BOEHRINGER INGELHEIM INTERNATIONAL GMBH CATALENT INC. CELESTICA INC. EVONIK INDUSTRIES AG FLEX LTD. HON HAI PRECISION INDUSTRY CO. LTD. JABIL INC. KINPO GROUP SHENZHEN KAIFA TECHNOLOGY CO. LTD. THERMO FISHER SCIENTIFIC INC. USI VENTURE CORP. LTD. WISTRON CORP. Related reports: Global Market Opportunities and Competitive Landscape for CDMO: This report provides a concise overview of the pharmaceutical industry with a focus on contract development and manufacturing organizations. It covers market segmentation by service type, drug molecule type, and end use, along with regulatory trends and competitive analysis. Key services include API and drug product manufacturing, development, and testing. The report also highlights major players, market share, and geographic revenue distribution across North America, Europe, Asia-Pacific, and other regions. Global Market for Contract Research Organization (CRO) Services: This report provides a detailed analysis of the global CRO services market, covering major companies and their roles in clinical trials. It breaks down the market by functional services such as clinical trials, preclinical research, drug discovery, and central labs, and by therapeutic areas like oncology, cardiology, and neurology. It also segments the market by end users and regions, offering insights into trends, the competitive landscape, regulatory factors, and future growth opportunities. Purchase a copy of the report direct from BCC Research. For further information on any of these reports or to make a purchase, contact info@ About BCC Research BCC Research market research reports provide objective, unbiased measurement, and assessment of market opportunities. Our experienced industry analysts' goal is to help you make informed business decisions free of noise and hype. Contact Us Corporate HQ: 50 Milk St., Ste. 16, Boston, MA 02109, USAEmail: info@ +1 781-489-7301 For media inquiries, email press@ or visit our media page for access to our market research library. Any data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. Logo - View original content to download multimedia: SOURCE BCC Research LLC
Yahoo
5 days ago
- Business
- Yahoo
Poly Medicure Ltd (BOM:531768) Q1 2026 Earnings Call Highlights: Strategic Expansion and ...
Release Date: August 08, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Poly Medicure Ltd (BOM:531768) was awarded Medical Device Provider of the Year 2025, highlighting its strong reputation in the healthcare sector. The company has signed two new contract manufacturing agreements, expanding its presence in the US and Hong Kong markets. Poly Medicure Ltd has established a wholly-owned subsidiary in Brazil, indicating a strategic move to expand its market presence in South America. The company's domestic revenue grew by 20% in Q1, with a significant increase in the private sector, reflecting a strong focus on sustainable domestic business. The company is investing in R&D, with a 20% increase in spending, to develop high-end technology segments such as cardiology and critical care. Negative Points International revenue saw a slight dip of 1% due to growth challenges in the European market and geopolitical uncertainties. The company faces challenges from tariffs imposed by the US, which could impact export markets. There is a slowdown in the infusion therapy business, primarily due to challenges in the European market. The company has lowered its international revenue growth guidance to 5-10% from the earlier 12-15%, reflecting current market uncertainties. The competitive intensity from Chinese companies in Europe has increased, affecting pricing and market dynamics. Q & A Highlights Warning! GuruFocus has detected 2 Warning Signs with BOM:531768. Q: Despite a lower international business, the gross margin was high during the quarter. What drove this margin, and what is sustainable for the full year? A: The gross margin historically tracks between 65% and 67%. As we delve deeper into critical cardiology areas, the product prices are higher, leading to higher gross margins. A run rate between 65% to 68% is sustainable. (Unidentified_3, Managing Director) Q: Can you explain the growth challenges in Europe and the expected easing in subsequent quarters? A: Europe faced financial restructuring and liquidity issues, leading to reduced inventory levels. However, demand is returning as inventory levels normalize, and we expect 5% to 10% growth in international business in the coming quarters. (Unidentified_3, Managing Director) Q: What are Poly Medicure's expansion plans for the HDF and CRRT portfolios in the renal segment? A: We plan to launch our first HDF machine in 2026, which is currently under development. CRRT is not a focus right now but may be considered for future development. (Unidentified_3, Managing Director) Q: Could you provide details on the contract manufacturing contracts in vascular and pain management? A: These are CDMO opportunities with innovative, patented devices. Revenue should start coming in from the next financial year, but it will take 2-3 years to scale up significantly. (Unidentified_3, Managing Director) Q: How is the company planning to address the competitive intensity from Chinese companies in Europe? A: The competitive intensity from Chinese companies has decreased, and we are seeing demand bounce back in Europe. We are confident that Europe will perform better in the current quarter. (Unidentified_3, Managing Director) For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Sign in to access your portfolio
Yahoo
29-06-2025
- Business
- Yahoo
Medical Device Contract Manufacturing Market to Reach $171.19 Billion by 2032, Growing at a CAGR of 9.9% from 2025, Says Meticulous Research®
Market Growth Driven by Outsourcing Preferences, Advanced Manufacturing Technologies, Regulatory Compliance Expertise, and Industry 4.0 Integration REDDING, Calif., June 29, 2025 /PRNewswire/ -- According to a comprehensive market research report titled "Medical Device Contract Manufacturing Market Size, Share, Forecast, & Trends Analysis by Device (Biochemistry, Immunoassay, CT, MRI, X-ray, Ultrasound, Pacemaker, Defibrillator, Oximeter) Services (Development, Manufacturing, QA) – Global Forecast to 2032", the Medical Device Contract Manufacturing market is projected to reach $171.19 billion by 2032, up from an estimated $84.8 billion in 2025, growing at a robust CAGR of 9.9% during the forecast period. The growth of the medical device contract manufacturing market is driven by increasing preference for outsourcing design, development, and manufacturing in the MedTech sector amid rising regulatory complexity and cost optimization needs. The market's expansion is fueled by advanced manufacturing technologies, changing regulatory landscapes requiring specialized expertise, Industry 4.0 adoption, and growing healthcare expenditure across key global markets. The industry is experiencing revolutionary transformation through sophisticated automation integration, AI and robotics adoption, and development of specialized regulatory compliance solutions. Leading companies are embracing digital manufacturing technologies while expanding into emerging markets and developing innovative value-added services for medical device manufacturers worldwide. For more comprehensive insights, download the FREE report sample: Revolutionary Market Transformation Through Specialized Manufacturing Excellence The medical device contract manufacturing market represents a paradigm shift in healthcare technology production and regulatory compliance optimization. As medical device companies increasingly prioritize core competencies like research and development while seeking specialized manufacturing expertise, contract manufacturing offers a revolutionary solution that addresses the growing demand for cost-effective, regulatory-compliant, and technologically advanced medical device production. Market leaders are investing heavily in advanced automation technologies and regulatory expertise, establishing manufacturing capabilities that can deliver scalable, compliant medical device solutions. This technological advancement is making sophisticated medical device manufacturing increasingly accessible while delivering superior quality and regulatory compliance benefits. Dynamic Growth Across Key Market Segments Based on device type, the IVD Devices segment dominates the market in 2025, capturing approximately 21% of the total market share due to high burden of chronic and infectious diseases propelling R&D in IVD, high preference for outsourcing immunoassay analyzer development, and growing demand for automated ELISA platforms. However, the Drug Delivery Devices segment is experiencing the fastest growth with 11.2% CAGR, driven by rising chronic disease incidence, growing adoption of biologic drugs, and trend toward self-administration of medications. Based on risk classification, the Moderate-risk Medical Devices segment leads the market, reflecting feasible outsourcing opportunities with careful regulatory compliance, frequent utilization of devices like syringes and catheters, and growing adoption in home healthcare settings. This segment is also anticipated to record the highest growth rate during the forecast period. Based on services, the Design & Development segment accounts for approximately 24% of the market in 2025, attributed to growing demand for advanced medical devices, high costs associated with device development, and increasing trend toward outsourcing technical expertise. This segment is also expected to register the highest CAGR of 11.7% during the forecast period. Get Insightful Data on Regions, Market Segments, Customer Landscape, and Top Companies (Charts, Tables, Figures and More) - Strategic Market Opportunities and Innovation Drivers The market presents extraordinary growth opportunities through Industry 4.0 technology integration, emerging market expansion, and development of specialized regulatory compliance services. Companies are discovering new revenue streams through advanced automation capabilities and vertical supply chain integration while establishing comprehensive medical device manufacturing ecosystems. Key market drivers include: Outsourcing Preference Growth: Increasing trend toward outsourcing design, development, and manufacturing enabling medical device companies to focus on core competencies while reducing costs and time-to-market Advanced Manufacturing Technologies: Integration of AI, robotics, additive manufacturing, and IoT solutions enhancing efficiency, precision, and customization capabilities in medical device production Regulatory Landscape Evolution: Changing regulatory requirements compelling companies to seek specialized regulatory expertise and compliance services from experienced contract manufacturers Industry 4.0 Integration: Adoption of digital technologies, smart manufacturing systems, and blockchain-enabled traceability improving operational efficiency and regulatory compliance Regional Market Leadership and Emerging Growth North America commands the largest market share in 2025 with approximately 44% of the global market, driven by well-developed manufacturing infrastructure, presence of leading contract manufacturers, high adoption of advanced manufacturing technologies, and strong academia-industry collaboration fostering technological capabilities. Asia-Pacific emerges as the fastest-growing region with a projected CAGR of 11.9% during 2025-2032, propelled by availability of skilled labor at competitive costs, rising quality standards in manufacturing, government initiatives for local medical device production, and good accessibility to cheaper raw materials. Europe represents a significant market, supported by stringent regulatory frameworks, advanced manufacturing capabilities, growing demand for specialized medical devices, and presence of leading contract manufacturing providers with emphasis on quality and compliance. Request a customized research analysis tailored to your specific requirements: Dynamic Competitive Landscape Driving Innovation The global medical device contract manufacturing market features an innovative competitive ecosystem comprising specialized contract manufacturers, electronics manufacturing services providers, and integrated healthcare technology companies. This diverse landscape fosters rapid technological advancement through sophisticated automation integration and specialized regulatory expertise development. Industry leaders are implementing integrated solutions that combine advanced manufacturing technologies with comprehensive regulatory services and quality assurance capabilities. Companies are pursuing strategic mergers and acquisitions while addressing scalability and compliance challenges across different medical device segments. Immediate Delivery Available | Buy this Research Report (Insights, Charts, Tables, Figures and More) - Market Leaders Shaping Industry Future Key players driving the global medical device contract manufacturing market include Jabil Inc. (U.S.), Gerresheimer AG (Germany), Nordson Corporation (U.S.), Teleflex Incorporated (U.S.), Celestica Inc. (Canada), Plexus Corp (U.S.), SteriPack Group Ltd (U.S.), Nortech Systems, Inc. (U.S.), Invetech Pty. Ltd. (Australia), Flextronics International, LTD. (Singapore), Benchmark Electronics Inc. (U.S.), Integer Holdings Corporation (U.S.), and STRATEC SE (Germany). These companies are focusing on strategies such as advanced automation technology integration, specialized regulatory expertise development, comprehensive service portfolio expansion, strategic mergers and acquisitions, and geographic expansion into emerging markets to strengthen their market position. Latest Industry Developments Recent market developments include: Strategic CDMO Partnerships: Formation of Contract Development and Manufacturing Organization partnerships for specialized immunoassay systems and cartridge-based reagent manufacturing enhancing market capabilities Advanced Automation Integration: Implementation of AI and robotics technologies improving manufacturing efficiency, precision, and scalability while reducing time-to-market for medical devices Vertical Integration Initiatives: Strategic acquisitions enabling companies to optimize supply chains, enhance core capabilities, and diversify service offerings across the medical device value chain Market Challenges and Opportunities While the market shows strong growth potential, it faces challenges including complex regulatory compliance requirements across different jurisdictions, intellectual property protection concerns for high-risk devices, maintaining quality standards while reducing costs, and technical complexity in advanced medical device manufacturing. However, significant opportunities exist in expanding Industry 4.0 technology adoption, growing healthcare expenditure in developing countries, increasing demand for personalized medical devices, emerging applications in digital health and connected medical devices, and rising need for specialized manufacturing expertise in complex therapeutic areas. The Mid-scale Medical Device Companies segment is projected to experience rapid growth during the forecast period, driven by increasing focus on innovation and product introduction while adhering to cost constraints, competitive pressures requiring advanced manufacturing capabilities, and partnerships with contract manufacturers to offer high-quality products at competitive prices. Related Reports: Pharmaceutical Contract Development and Manufacturing Market Pharmaceutical Contract Packaging Market by Size, Share, Forecasts, & Trends Analysis IVD Contract Manufacturing Services Market by Size, Share, Forecasts IVD Assay Development Market Size, Share, Growth Analysis 2031 About Meticulous Research We are a trusted research partner for leading businesses worldwide, empowering Fortune 500 organizations and emerging enterprises with market intelligence designed to drive revenue transformation and strategic growth. Our insights reveal future growth opportunities, equipping clients with a competitive edge through a versatile suite of research solutions—including syndicated reports, custom research, and direct analyst engagement. To find out more, visit or follow us on LinkedIn Contact: Mr. Khushal Bombe Meticulous Market Research Pvt. Ltd. 1267 Willis St, Ste 200 Redding, California, 96001, U.S. USA: +1-646-781-8004 Europe: +44-203-868-8738 APAC: +91 744-7780008 Email- sales@ Visit Our Website: Connect with us on LinkedIn- Content Source: Logo - View original content to download multimedia: SOURCE Meticulous Market Research Private Limited Sign in to access your portfolio
Yahoo
20-05-2025
- Business
- Yahoo
Topical Drugs Contract Manufacturing Industry Report 2025-2030: Demand for Dermatological Treatments and Non-Invasive Drug Delivery Drives CMO Market Expansion
India, China, and South Korea Offer Competitive Pricing and Rapid GMP-Compliant Infrastructure Growth Dublin, May 20, 2025 (GLOBE NEWSWIRE) -- The "Topical Drugs Contract Manufacturing Market Size, Share & Trends Analysis by Product Type (Semi-Solid Formulations, Solid Formulations), Scale of Operation (Clinical), End-use (Pharmaceutical Companies), Region, with Growth Forecasts, 2025-2030" report has been added to Topical Drugs Contract Manufacturing Market was valued at USD 29.25 Billion in 2024, and is projected to reach USD 54.55 Billion by 2030, rising at a CAGR of 11.05%. Currently, the global market for contract manufacturing of topical drugs is currently experiencing significant growth, driven by evolving therapeutic needs, outsourcing trends, and advancements in technology. Moreover, with the increasing prevalence of dermatological conditions, coupled with a rising geriatric population and a preference for non-invasive drug delivery methods such as creams, gels, ointments, sprays, and transdermal patches has made outsourcing services like Contract Manufacturing Organizations (CMOs) essential for optimizing costs, ensuring regulatory compliance, and enhancing production capabilities. In addition, CMOs offer numerous advantages that support streamline operations, lower in-house manufacturing expenses, and speed up product commercialization, further contributing to market expansion. In addition, with the rising consumer demand for topical drugs, outsourcing has become a strategic priority, particularly for semi-solid and transdermal product lines that require specialized expertise and adaptable infrastructure. Furthermore, cost dynamics play a crucial role in the growth of the market. Based on the pricing analysis, the North America provides high-quality manufacturing that complies with regulatory standards, while the Asia-Pacific's countries like India, China, and South Korea offers more cost-effective production options with growing capabilities. Factors such as lower labor costs, supportive government policies, and a developing infrastructure complaint with Good Manufacturing Practices (GMP) are fueling the market in Asia-Pacific. Furthermore, technological innovations such as continuous manufacturing, nanoencapsulation, advanced homogenization, and 3D printing are improving formulation accuracy, bioavailability, and batch consistency. These advancements support the CMOs to meet complex product demands and meet rising consumer expectations for efficacy and pricing models are evolving with aligning financial results with performance. However, external factors like U.S. tariffs on imported active pharmaceutical ingredients (APIs) and excipients have created cost pressures in the supply chain, particularly impacting exporters. Despite these challenges, the market is expected to witness growth during the forecast period. Likewise, strategic initiatives and accelerating product launches drive the market. For instance, in July 2024, Arcutis Biotherapeutics, Inc. announced the release of ZORYVE cream 0.15% for the treatment of mild to moderate atopic dermatitis in both adults and children under 6 in the U.S. This new cream, which is applied once daily and contains no steroids, provides quick relief from symptoms and reduces itching, allowing for better long-term management of the condition. Such innovations are expected to further propel the market during the forecast Drugs Contract Manufacturing Market Report Highlights The semi-solid formulations segment dominated the market, with a share of 65.54% in 2024. This growth is driven by the increasing prevalence of skin diseases, patient preferences for targeted therapies, the convenience of semi-solid formulations, and the demand for improved drug absorption, stability, and aesthetic appeal within both therapeutic and cosmetic sectors. Based on the scale of operation, the commercial segment held the largest market share in 2024, attributed to the growing trend toward outsourcing, increased demand for dermatological and transdermal therapies, regulatory compliance, increased cost efficiency, and the rising complexity of formulations that require specialized manufacturing expertise. The pharmaceutical companies segment held the largest market share in 2024 based on end-use. These companies leverage CMO services due to increasing demand for non-invasive therapies, treatments for chronic skin conditions, improved patient compliance, and opportunities within cosmetic dermatology and advanced transdermal drug delivery systems. North America is expected to register a growth rate of 10.37% CAGR over the forecast period due to the rising number of contract manufacturing organizations(CMOs) in countries such as the U.S. and Canada. In addition, the availability of a skilled workforce and regulatory scenarios are expected to significantly contribute to the market's expansion in this region. Why Should You Buy This Report? Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments. Competitive Landscape: Explore the market presence of key players. Future Trends: Discover the pivotal trends and drivers shaping the future of the market. Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions. This report addresses: Market intelligence to enable effective decision-making Market estimates and forecasts from 2018 to 2030 Growth opportunities and trend analyses Segment and regional revenue forecasts for market assessment Competition strategy and market share analysis Product innovation listings for you to stay ahead of the curve Key Attributes Report Attribute Details No. of Pages 120 Forecast Period 2024-2030 Estimated Market Value (USD) in 2024 $29.25 Billion Forecasted Market Value (USD) by 2030 $54.55 Billion Compound Annual Growth Rate 11% Regions Covered Global The companies profiled in this Topical Drugs Contract Manufacturing market report include: MedPharm DPT Laboratories Ltd. Cambrex Corporation Kindeva Drug Delivery AbbVie Contract Manufacturing NextPharma Catalent Pharma Solutions Thermo Fisher Scientific Lonza Group The Lubrizol Corporation SGS SA Bora Pharmaceutical CDMO For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
